semaglutide tracking sheet Injection Tracker Semaglutide Weight Loss Tracker Logbook:

It remains uncertain whether the lack of improvements in CV death associated with intensive glycemic control in individuals with T2D also extends to those with prediabetes or to interventions involving newer pharmacological agents such as GLP-1RAs and SGLT2 inhibitors (7477)

The debate over compounded GLP-1s has played out in ad battles

Escalating every 2 weeks might seem like it will get you to the effective dose faster, but it dramatically increases the risk of severe nausea, vomiting, and diarrhea that could force you to stop entirely

After a year of treatment, semaglutide led to an average 14.9% weight loss, with about a third of patients losing over 20%

Elderly patients and those with comorbidities such as chronic kidney disease are at higher risk of dehydration and subsequent acute kidney injury